Enrollees in Feinberg’s Master of Science in Clinical Investigation (MSCI) program developed research projects including a yoga intervention for patients with Parkinson’s disease and a cardiovascular risk assessment for cholesterol guidelines.
Northwestern Medicine scientists have identified two drugs that stimulate stem cells in the central nervous system with the potential to repair the protective coating around neurons damaged in multiple sclerosis.
Feinberg has been chosen by The Michael J. Fox Foundation for Parkinson’s Research to host one of five inaugural Edmond J. Safra Fellowships in Movement Disorders, a specialized training program for clinician-researcher neurologists.
The Les Turner ALS Research and Patient Center at Northwestern Medicine has commissioned an ice sculpture exhibition to bring attention to specific people with ALS and the debilitating effects of the disease.
Evangelos Kiskinis, PhD, assistant professor in Neurology and Physiology, uses stem cells to study the motor neurons and genes implicated in ALS.
Northwestern Medicine scientists have found a signaling pathway that contributes to motor neuron degeneration in spinal muscular atrophy, and may help to better understand other neurodegenerative disorders.
Two independent pathways in the human brain evaluate the identity and the value of expected outcomes, according to a Northwestern Medicine study that used appetizing odors to examine brain activity.
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM) when delivered using spherical nucleic acid nanoparticles.
A new Northwestern Medicine study reveals that white matter loss is associated with impaired verbal abilities, an important implication for cognitive recovery following traumatic brain injury.
A new Northwestern Medicine study shows an experimental gene therapy may have promise for treating painful diabetic neuropathy.
